logo
#

Latest news with #EPS

Investors in Hong Fok (SGX:H30) have unfortunately lost 19% over the last three years
Investors in Hong Fok (SGX:H30) have unfortunately lost 19% over the last three years

Yahoo

time5 hours ago

  • Business
  • Yahoo

Investors in Hong Fok (SGX:H30) have unfortunately lost 19% over the last three years

For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term Hong Fok Corporation Limited (SGX:H30) shareholders, since the share price is down 22% in the last three years, falling well short of the market return of around 32%. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the three years that the share price fell, Hong Fok's earnings per share (EPS) dropped by 21% each year. In comparison the 8% compound annual share price decline isn't as bad as the EPS drop-off. This suggests that the market retains some optimism around long term earnings stability, despite past EPS declines. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, Hong Fok's TSR for the last 3 years was -19%, which exceeds the share price return mentioned earlier. This is largely a result of its dividend payments! Investors in Hong Fok had a tough year, with a total loss of 4.9% (including dividends), against a market gain of about 23%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 3% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Hong Fok better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Hong Fok , and understanding them should be part of your investment process. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $384.84 · 0.2% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Those who invested in Greenbrier Companies (NYSE:GBX) five years ago are up 149%
Those who invested in Greenbrier Companies (NYSE:GBX) five years ago are up 149%

Yahoo

time16 hours ago

  • Business
  • Yahoo

Those who invested in Greenbrier Companies (NYSE:GBX) five years ago are up 149%

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far more than 100% on a really good stock. For instance, the price of The Greenbrier Companies, Inc. (NYSE:GBX) stock is up an impressive 115% over the last five years. Meanwhile the share price is 2.4% higher than it was a week ago. Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. During five years of share price growth, Greenbrier Companies achieved compound earnings per share (EPS) growth of 24% per year. The EPS growth is more impressive than the yearly share price gain of 17% over the same period. So one could conclude that the broader market has become more cautious towards the stock. The reasonably low P/E ratio of 7.28 also suggests market apprehension. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). We know that Greenbrier Companies has improved its bottom line over the last three years, but what does the future have in store? This free interactive report on Greenbrier Companies' balance sheet strength is a great place to start, if you want to investigate the stock further. It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Greenbrier Companies' TSR for the last 5 years was 149%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence! Greenbrier Companies shareholders are down 1.9% for the year (even including dividends), but the market itself is up 15%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 20% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Greenbrier Companies (at least 2 which are a bit unpleasant) , and understanding them should be part of your investment process. For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note

Yahoo

timea day ago

  • Business
  • Yahoo

Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note

Bristol Myers Squibb (BMY) closed the most recent trading day at $47.51, moving +2.64% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 0.11%. On the other hand, the Dow registered a gain of 0.91%, and the technology-centric Nasdaq decreased by 0.82%. The biopharmaceutical company's stock has dropped by 5.12% in the past month, falling short of the Medical sector's gain of 1.66% and the S&P 500's gain of 5.17%. Investors will be eagerly watching for the performance of Bristol Myers Squibb in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 31, 2025. The company is predicted to post an EPS of $1.53, indicating a 26.09% decline compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $11.32 billion, reflecting a 7.19% fall from the equivalent quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $6.76 per share and revenue of $46.3 billion, indicating changes of +487.83% and -4.13%, respectively, compared to the previous year. Investors should also pay attention to any latest changes in analyst estimates for Bristol Myers Squibb. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2% decrease. Bristol Myers Squibb currently has a Zacks Rank of #3 (Hold). Looking at valuation, Bristol Myers Squibb is presently trading at a Forward P/E ratio of 6.85. This denotes a discount relative to the industry average Forward P/E of 18.72. It is also worth noting that BMY currently has a PEG ratio of 1.37. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Medical - Biomedical and Genetics stocks are, on average, holding a PEG ratio of 1.34 based on yesterday's closing prices. The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 85, finds itself in the top 35% echelons of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply to follow these and more stock-moving metrics during the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Berenberg Upgrades Autodesk (ADSK) Stock to Buy from Hold
Berenberg Upgrades Autodesk (ADSK) Stock to Buy from Hold

Yahoo

timea day ago

  • Business
  • Yahoo

Berenberg Upgrades Autodesk (ADSK) Stock to Buy from Hold

Autodesk, Inc. (NASDAQ:ADSK) is one of the Top 10 AI and Technology Stocks to Buy According to Analysts. On June 27, Berenberg upgraded the company's stock to 'Buy' from 'Hold' with a price objective of $365, an increase from the prior target of $325, as reported by The Fly. The firm noted a compelling margin-expansion opportunity at Autodesk, Inc. (NASDAQ:ADSK). Unlike earlier AI tools, which simply improved user productivity, the AI agents have the ability to execute business tasks with full autonomy and agency, according to the firm's analyst. A software engineer using AutoCAD Civil 3D to create a 3D design in a modern office setting. The firm believes that this technological advance unlocks fundamental new value in AI adoption for enterprises, and this trend can benefit Autodesk, Inc. (NASDAQ:ADSK). The company is focusing its growth investments on the strategic priorities in cloud, platform, and AI. Furthermore, it continues to optimize its sales and marketing and has been investing to enable future optimization, which fuels higher margins. For Q2 2026, Autodesk, Inc. (NASDAQ:ADSK) expects revenue in the range of $1,720 million – $1,730 million, and EPS (GAAP) of between $1.37 – $1.46. Autodesk, Inc. (NASDAQ:ADSK) is a leading AI and technology business because it is engaged in developing advanced software platforms for engineering, design, and manufacturing. The company uses AI for the automation of design processes and optimization of construction planning. Parnassus Investments, an investment management company, released its Q3 2024 investor letter. Here is what the fund said: 'In Software, we added Autodesk, Inc. (NASDAQ:ADSK) and Cloudflare while exiting We believe Autodesk's dominant position in architecture, engineering and construction software allows it to increase margins and offer attractive revenue growth. Autodesk is a market-leading vertical software company with the ability to meaningfully improve its margins, while its revenue growth should accelerate as it completes its sales channel re-alignment.' While we acknowledge the potential of ADSK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ADSK and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds' investor letters by entering your email address below.

Zhongmin Baihui Retail Group (SGX:5SR investor three-year losses grow to 28% as the stock sheds S$21m this past week
Zhongmin Baihui Retail Group (SGX:5SR investor three-year losses grow to 28% as the stock sheds S$21m this past week

Yahoo

timea day ago

  • Business
  • Yahoo

Zhongmin Baihui Retail Group (SGX:5SR investor three-year losses grow to 28% as the stock sheds S$21m this past week

For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. We regret to report that long term Zhongmin Baihui Retail Group Ltd. (SGX:5SR) shareholders have had that experience, with the share price dropping 30% in three years, versus a market return of about 32%. And the share price decline continued over the last week, dropping some 18%. Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Zhongmin Baihui Retail Group moved from a loss to profitability. That would generally be considered a positive, so we are surprised to see the share price is down. So it's worth looking at other metrics to try to understand the share price move. With a rather small yield of just 1.9% we doubt that the stock's share price is based on its dividend. Arguably the revenue decline of 4.5% per year has people thinking Zhongmin Baihui Retail Group is shrinking. After all, if revenue keeps shrinking, it may be difficult to find earnings growth in the future. The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers). Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Zhongmin Baihui Retail Group, it has a TSR of -28% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! Investors in Zhongmin Baihui Retail Group had a tough year, with a total loss of 17% (including dividends), against a market gain of about 23%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 2% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 5 warning signs for Zhongmin Baihui Retail Group you should be aware of, and 3 of them make us uncomfortable. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store